Followers | 1392 |
Posts | 28472 |
Boards Moderated | 43 |
Alias Born | 12/10/2012 |

Friday, December 23, 2022 9:49:12 AM
Recent ORIC News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/24/2025 08:05:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/23/2025 04:15:22 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2025 08:05:24 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/11/2025 08:05:51 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/06/2025 08:30:00 PM
- ORIC Pharmaceuticals Shares Rally 20% on Encouraging Cancer Drug Trial and Funding Update • IH Market News • 05/29/2025 02:21:33 PM
- ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing • GlobeNewswire Inc. • 05/28/2025 08:05:00 PM
- ORIC® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data from Ongoing Phase 1b Trial of ORIC-944 in Combination with AR Inhibitors for the Treatment of Patients with mCRPC • GlobeNewswire Inc. • 05/28/2025 08:05:00 PM
- ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/27/2025 08:30:00 PM
- ORIC® Pharmaceuticals to Present Initial Data from Phase 1b Trial of ORIC-944 in Combination with Androgen Receptor Inhibitors in Patients with mCRPC • GlobeNewswire Inc. • 05/27/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2025 08:20:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2025 08:10:07 PM
- ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates • GlobeNewswire Inc. • 05/05/2025 08:05:00 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/02/2025 08:30:00 PM
- ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of ORIC-944 as a Best-in-Class PRC2 Inhibitor for the Treatment of Prostate Cancer at the 2025 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 04/28/2025 08:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/23/2025 08:10:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/23/2025 08:06:42 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/04/2025 08:30:00 PM
- ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/31/2025 08:30:00 PM
- ORIC® Pharmaceuticals Announces ORIC-944 Preclinical Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/25/2025 08:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/20/2025 08:25:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/14/2025 08:02:17 PM
FEATURED MedWellAi, Inc (formerly Integrated Ventures) Completes Corporate Rebranding And Transformation Into Ai-Driven Healthcare and Wellness • Jun 24, 2025 8:45 AM
FEATURED Envirotech (EVTV) Announces Vision for Multi-modal Electric Mobility Ecosystem • Jun 24, 2025 8:42 AM
Avant Technologies Creating New Company for Expansion of Diabetes Program • AVAI • Jun 24, 2025 8:00 AM
From Exploration to Execution: New Gold Player Emerges in One of Canada's Premier Mining Districts • ABX • Jun 23, 2025 8:45 AM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM